GSK-110870

Study Sponsor: GSK

Study Title

Immunogenicity & safety study of a booster dose of GSK Biologicals’ meningococcal vaccine 134612 given at 12-15 months of age or at 15-18 months of age (co-administered with Infanrix®) in primed healthy toddlers.

Medicine or Vaccine (generic name)

Meningococcal Serogroups A, C, W-135 and Y-Tetanus Toxoid Conjugate Vaccine

Sponsor Identification Number

110870

Trial Registry Identification Number(#'s)

NCT00614614 2012-002401-22

Medical Condition

Infections, Meningococcal

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=110870

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00614614

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2012-002401-22

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Booster study 110871 was conducted. The results are summarised with this study 110870 on the GSK Study Register.

Date Added to this Site

June 2015